16 citations
,
May 2013 in “Australasian Journal of Dermatology” In this study, detailed examinations of alopecic lesions in two female Cronkhite-Canada syndrome patients suggested hair regrowth might occur without systemic corticosteroids if not required for gastrointestinal treatment, and hair loss may begin with anagen-telogen transition.
113 citations
,
November 2017 in “Scientific Reports” This study found that treatment with mesenchymal stem cell extracellular vesicles enhanced hair growth in mice and stimulated dermal papilla cell activity and growth factor production in vitro.
1 citations
,
January 2023 in “Drug Development and Industrial Pharmacy” This study observed that DMSO-modified liposomes enhanced the topical delivery of finasteride, improving hair follicle density and growth phase ratio in a rat model of testosterone-induced alopecia.
1 citations
,
February 2017 in “Journal of pharmacology & clinical research” This study found that topical gel formulations containing extracts of Eclipta alba and Lippia nodiflora significantly increased hair growth in black mice over 30 days, with a combination of both extracts showing greater effectiveness than either alone.
2 citations
,
August 2017 in “British Journal of Dermatology” Hair loss in Cronkhite-Canada syndrome may be due to an autoimmune response.